Published in Telemedicine Law Weekly, January 13th, 2007
This trend article about University Hospital, Basel, Switzerland, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A new study, "Serum immunoglobin G4 (IgG4): an important marker in autoimmune pancreatitis," is now available. According to a study from Basel, Switzerland, "A unique form of chronic pancreatitis has recently become widely recognised as an important clinical entity in the spectrum of pancreatic diseases under the term autoimmune pancreatitis (AIP). This entity is characterised by irregular narrowing of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.